Analytics
- Ref-No. Technology
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
02-99999
Metax: Cross-Domain Metagenomic Profiling Technology
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
-
10-00126
Cytotoxicity Assay for detecting Cellular Damage
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
-
32-00030
Method and arrangement for identification and correction of optical aberrations
-
32-00071
A scalable and highly sensitive assay for measuring extracellular NAD+ level in human body fluids
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
Animal Models
- Ref-No. Technology
-
02-00425
Efficient Generation of Murine Brain Organoids from Adult Neural Stem Cells
-
03-00144
Mice with Kidney-specific Megalin Gene Defect
-
03-00145
Kinin B1 Receptor Knock-Out Mice
-
03-00184
Double-Transgenic Rats as a Tool to Study the Function of the Renin-Angiotensin System
-
03-00188
Tryptophan Hydroxylase 1 Knockout Mice as a Tool to Study the Function of Serotonin
-
03-00189
TGR(hKLK1) Transgenic rats as a Tool to Study the Kallikrein-Kinin System
-
03-00190
Angiotensinogen Transgenic Mice TGM(rAOGEN)123
-
03-00202
Renin Transgenic Rat TGR(mREN2)27
-
03-00238
Conductin+/lacZ-mice as a model for Wnt-mediated tumorigenesis
-
03-00244
CCR7 -/- mice: a model for studies on early immune reponses towards alloantigens
-
03-00249
SLP3 mutant mice; an animal model lacking touch-evoked neuropathic pain
-
03-00300
Animal model for endotoxic shock: transgenic rats with endothelial overexpression of kinin B1 receptors
-
03-00495
A titin-DsRed knock-in mouse model to study cardiac and skeletal muscle disorders
-
03-00504
A titin-eGFP knock-in mouse model to study cardiac and skeletal muscle disorders
- 11-00041 PARP1 -/- mice: an animal model for cancer, autoimmune encephalomyelitis, arthritis and diabetes
- 11-00046 GFP Transgenic Zebrafish strain as tool for studying kidney development
-
11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
- 21-00013a MAG -/- mice: a model for studying pathological mechanisms of acquired demyelinating diseases
- 21-00013b Tenascin-R knock-out mice
- 21-00013c CHL1 -/- mice: a model for studying the function of the close homologue of adhesion molecule L1
-
43-00017
SCON – Artificial intron devoid of hypomorphic target gene effects for one-step generation of conditional animal models
- 002249 B10.129S2(B6)-Igh-6tm1Cgn/J
- 002250 B10.129P2(B6)-Il10tm1Cgn/J
- 002251 B6.129P2-Il10tm1Cgn/J
- 002253 B6.129P2-Il4tm1Cgn/J
- 002288 B6.129S2-Igh-6tm1Cgn/J
- 002397 129-Cd5tm1Cgn/J
- 002399 129-Igh-5tm1Cgn/J
- 002400 C57BL/6-Igk-Ctm1Cgn/J
- 002401 B6.129S2-Igll1tm1Cgn/J
- 002405 B6.129P2-Ncam1tm1Cgn/J
- 002438 B6.129P2-Igh-Jtm1Cgn/J
- 002479 STOCK Il2rgtm1Cgn/J
- 002527 STOCK Tg(Mx1-cre)1Cgn/J
- 002538 C.129P2(B6)-Igh-5tm1Cgn/J
- 002858 STOCK Tg(balancer1)2Cgn/J
- 002859 STOCK Tg(balancer2)3Cgn/J
- 002965 C57BL/6-Itgb7tm1Cgn/J
- 003465 BALB/c-Tg(CMV-cre)1Cgn/J
- 003556 B6.Cg-Tg(Mx1-cre)1Cgn/J
- 003968 C3Bir.129P2(B6)-Il10tm1Cgn/J
- 004126 C.129P2-Cd19tm1(cre)Cgn/J
- 004192 STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J
- 004222 NOD.129P2(B6)-Il4tm1Cgn/DvsJ
- 004254 NOD.Cg-Igh-6tm1Cgn Tg(IghelMD4)4Ccg/Dvs
- 004266 NOD.Cg-Il10tm1Cgn/DvsJ
- 004291 NOD.Cg-Il10tm1Cgn Il4tm1Cgn/DvsJ
- 004326 C3Bir.129P2(B6)-Il10tm1Cgn/Lt
- 004333 C.129P2(B6)-Il10tm1Cgn/J
- 004349 C.129S2-Igh-6tm1Cgn/J
- 004368 129-Il10tm1Cgn/J
- 004639 NOD.129S2(B6)-Igh-6tm1Cgn/DoiJ
- 004781 B6.129P2-Lyzstm1(cre)Ifo/J
- 004943 NOD.Cg-Selltm1Tft Itgb7tm1Cgn/LtJ
- 004944 NOD.B6-Itgb7tm1Cgn/2Lt
- 004982 C3Bir.Cg-Il10tm1Cgn (D3Mit11-D3Mit19)/Lt
- 005306 NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ
- 005309 NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6)2Mjsk/FswJ
Antibodies
- Ref-No. Technology
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00515
Advancing Bioproduction: HDLBP overexpression enhances protein production and secretion
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
- 17beta-HSDcl
-
Contactin1, mouse/chicken, mouse monoclonal
- ACP33 acidic cluster protein 33, ligand of CD4
- APRIL
- APRIL-Phosphothreonin 224
- ActA purified, several epitopes
- Activation-induced cytidine deaminase (AID)
- Adenovirus type 5, E1B-55 kDa
- Adenovirus type 5, E4orf3
- Adenovirus type 5, L4-100 kDa
- Ago 1
- Ago 2
- BRD7, human, cellular
- Blocking, FC gamma receptor, mouse, several isotypes
- Bop1 (human, block of proliferation)
- Borna gp18
- Borna p24
- Borna p40
- Borna p56
- C-24
- C-Myc, N-term
- C1q, C3, C4, mouse
- C1q, human
- CBF1 (CSL, Su(H), RBP-1)
- CCR9
- CD154, human, monkey
- CD155
- CD3 epsilon chain
- CD4, mouse
- CD44, canine
- CD49c
- CD8, mouse
- CD83, human
- CD96
- CDs, several, dog
- CDs, several, dog
- CNG channel alpha3, rat
- CNG channel, cone type, rat
- CYTIP
- Calcitonin
- Canine, CD44
- Cdc45 cell division cycle 45p
- Cellular, BRD7, human
- Chicken, GTP cyclohydrolase
- Chicken, Interferon -γ
- Chicken, Interferon, alpha
- Chimerin
- Cyclodextrinase, Klebsiella oxytoca
- Cythohesin-1
- Cytomegalievirus, glycoprotein gp40
- DLL1
- DNA pol delta p125 subunit
- DNA pol delta p50 subunit
- DUTPase, EBV
- Dead box protein, DP103
- Dead box protein, DP103
- Dog, several CDs
- Dog, several CDs
- E1B AP5 / HNRPUL1, Ribonucleoprotein hnRNP
- EBNA-3A
- EBV, BHRF1
- EBV, EBNA1
- EBV, EBNA2, several epitopes
- EBV, EBNA2, wwp-peptide
- EBV, EBNA2A, several epitopes
- EBV, EBNA2b, several epitopes
- EBV, LMP1, several epitopes
- EBV, LMP2a, TP, several epitopes
- EBV, dUTPase
- EDG
- ENV, Herv K10
- ENV, Herv K10
- ENV, Herv K10
- Epitopes, several, HIV-2, Nef protein
- Epsilon chain, Protein kinase C
- FC gamma receptor, mouse, blocking, several isotypes
- FITC
- FLT-1
- Formin-related protein in leukocytes 1
- GTP cyclohydrolase, chicken
- GTP cyclohydrolase, human
- GTP cyclohydrolase, murine
- Gag protein, Herv K10
- Guanylate binding protein GBP-1
- H2BUb1 (histone2B, ubiquintylated)
- H3X
- HCMV, US28
- HHV8, Kaposin
- HHV8, majorcapsid antigen (OFR 25)
- HHV8, minor capsid antigen (ORF 26)
- HHV8m, dUTPase
- HIV-2, Nef protein, several epitopes
- HSP72
- Helt
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, gag protein
- Histone H3, K27 dimethylated
- Histone H4, K20 methylated
- Hmd, Methanothermobacter
- Hmd, Methanothermobacter
- Human cellular, USP7/HAUSP
- Human origin recognition complex, OCR1 (hsORC)
- Human origin recognition complex, OCR2 (hsORC)
- Human origin recognition complex, OCR6 (hsORC)
- Human origin recognition complexOCR3 (hsORC)
- Human, C1q
- Human, CD154, monkey
- Human, GTP cyclohydrolase
- Human, Importin a1
- Human, Importin a3
- Human, Importin a4
- Human, Importin a5
- Human, Importin a7
- Human, Methyltrans-ferase PRMT2
- Human, Notch1 intracellular, mouse
- Human, Notch3, intracellular
- Human, PAX9, murine
- Human, Replication protein A, RPA32
- Human, Replication protein A, RPA70
- Human, cellular, BRD7
- Human, primase, p58, p48
- Hyperpolarization-activated Channel HCN1
- Hyperpolarization-activated channel HCN2
- Hyperpolarization-activated channel HCN3
- Hyperpolarization-activated channel HCN4
- Id, mouse lymphoma
- IgG2c, rat
- Ink4a
- Interferon alpha, chicken
- Isotypes, several, FC gamma receptor, mouse, blocking
- Isotypes, various, murine CD45
- Jul 1C11
- K20 methylated, Histone H4
- Kaposin, HHV8
- Karyopherin alpha2, Rch1
- LARK
- LARK/RBM4A
- LCMV-gp44 (Klon 25)
- Lambda light chain, rat
- Listeria monocytogenes Internalin B, Dhly pfrA 7973
- Listeria supernatant EDGprfA+
- Listeria supernatant EDGprfA+
- Listeria supernatant, complete
- Listeria supernatant, electro-elualed bands
- Listeria supernatant, eletro-elualed bands
- Ly1.1, Mouse anti mouse CD5
- Ly1.2, Mouse anti mouse CD5
- Lyt-1, mouse
- M161Ag
- MAD1
- MBP, maltose-binding protein, rat
- Mage11
- Methanothermobacter, Hmd
- Methanothermobacter, Hmd
- Methyltransferase PRMT2, human
- Monkey, human, CD154
- Motifantibody Poly DE
- Motifantibody Poly PRO
- Mouse IRS-2
- Mouse IRS-2
- Mouse Lyt-1
- Mouse anti mouse CD5, Ly1.1
- Mouse anti mouse CD5, Ly1.2
- Mouse anti-MBP, maltose binding protein
- Mouse anti-TrpE
- Mouse lymphoma, ld
- Mouse, C1q, C3, C4
- Mouse, CD4
- Mouse, CD8
- Mouse, RmT1, RmT2, RmT5, anti-Thy1
- Mouse, Thy1.2, spleen AKR
- Mouse, Thy1.2, spleen CBL
- Mouse, several Isotypes, FC gamma receptor, blocking
- Murine CD45, various isotypes
- Murine, GTP cyclohydrolase
- Murine, PAX9, human
- N-term, C-Myc
- NCAM AB – 5A2
- Nef protein, several epitopes, HIV-2
- Notch1 intracellular, mouse, human
- Notch3, intracellular, human
- OCR1, human origin recognition complex (hsORC)
- OCR2, human origin recognition complex (hsORC)
- OCR3, human origin recognition complex (hsORC)
- OCR6, human origin recognition complex (hsORC)
- PAX1
- PAX9, murine, human
- PAY, PC2 associated Q-rich protein
- PCNA
- PF1
- PF63.1
- PP32
- Pes1 (human, pescadillo, rRNA processing factor)
- Pirin
- Primase, p58, p48, human
- Protein kinase C, epsilon chain
- Protein kinase C, zeta chain
- Protein phosphatase 2A
- RBM4A
- RBM4B
- RBM4B
- RBP (CBF1)
- RISP
- RNA Polymerase II - CTD (non-phosporylated)
- RNA Polymerase II - CTD-Ser2-P
- RNA Polymerase II - CTD-Ser5-P
- RNA Polymerase II - CTD-Ser7-P
- RNA Polymerase II - CTD-Thr4-P
- RNA Polymerase II - CTD-Tyr1-P
- Rat IgG2c
- Rat anti-GST, synergistic to M-GST
- Rat anti-trpE
- Rat, MBP, maltose-binding protein
- Rat, lambda light chain
- Rch1, Karyopherin alpha2
- Replication protein A, RPA14
- Replication protein A, RPA32, human
- Replication protein A, RPA70, human
- Ribonucleoprotein hnRNP, E1B AP5 / HNRPUL1
- RmT1, RmT2, RmT5, anti-Thy1, mouse
- SH2D1A (X-linked lymphoproliferative disease XLP)
- Sepiapterin reductase
- TCR
- TMEM59
- TRAF1
- TRAF2
- Tenascin-R
- Thy1.2, mouse, spleen AKR
- Thy1.2, mouse, spleen CBL
- Transcription Cofactor NC2 alpha
- TrpE, Rat
- US28, HCMV
- USP7/HAUSP, human cellular
- UTP18 (human, rRNA processing factor)
- VIII41, ZBP-89
- WDR12 (WD-repeat 12, rRNA processing factor)
- Yku70, yeast
- Zeta chain, Protein kinase C
- dUTPase, human
- dog C1q
- wwp-peptide, EBV, EBNA2
Bioinformatics
- Ref-No. Technology
-
02-00429
WarpDemuX - Method for Demultiplexing of RNA-sequencing DATA
-
02-99999
Metax: Cross-Domain Metagenomic Profiling Technology
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
Cardiovascular
- Ref-No. Technology
-
01-01070
AI-based Method and Tool (DeepNeo) for Intravascular Optical Coherence Tomography Image Analysis of Coronary Artery Neointimal Tissue
-
03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
-
15-00411
Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
-
15-00433
Bioartificial vascular grafts based on a highly compacted acellular fibrin matrix
-
15-00733
Automated production of cardiac organoids
-
32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
Chemical Synthesis
CNS
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 03-00367 Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
-
03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
-
03-00493
Self-Organizing Human 2D Neuromuscular Junction Model and 3D Neuromuscular Organoids
-
11-00068
Dream Complex Inhibitors for Treating Medical Conditions Induced by Circadian Rhythm Disruption
-
15-00617
Spider silk/fibrin implant for the regeneration of injured spinal cord
-
15-00785
Novel CARs for the Treatment of Multiple Sclerosis and Alzheimer´s Disease
-
21-00019
Microelectrode array with combined optical stimulation
-
21-00027
Ferulic acid derivatives as efficient neuroprotective agent and memory enhancer
-
21-00035
Novel Therapy for Treatment of Alzheimer´s Disease
-
23-00046
microRNA Signature Indicates Risk for Cognitive Decline
-
23-00054
Vinpocetine inhibiting PDE1, a target for disease modifying therapy of synucleinopathies like multiple system atrophy (MSA)
-
23-00064
Treating dementia and other brain disorders with natural glycans
- 23-00065 Novel treatment of dementia-associated tauopathies
-
23-00069
NMDAR targeted CAAR-T cell therapy
- 23-00074 Treating C9orf72 ALS/FTD with active vaccination
-
23-00075
HERV inhibitors for use in tauopathies
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
COVID-19 Related Technologies
- Ref-No. Technology
-
01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
-
02-00311
Cystobactamids – novel antibacterials against gram-negative pathogens
-
02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
-
03-00461
Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
- 07-00080 Innovative plasmids and cells for SARS-CoV-2-specific research
-
14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
Dermatology
Diagnostics
- Ref-No. Technology
-
01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
02-00324
Innovative DOTA-Linkers for Bacterial Targeting
-
02-00351
Increased Availability and Efficacy of Aminoglycosides
-
02-00375
CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
-
02-00396
Novel Lectin-Targeting therapeutics and diagnostics for Pseudomonas aeruginosa infections
-
02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
-
02-00434
Programmable RNA-Guided Enzymes and Novel Orthogonal Substrates for Crispr Diagnostics
- 03-00367 Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
-
03-00448
Method and kit for early detection of preeclampsia
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
-
03-00470
FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
-
03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
-
03-00523
Diagnostic assay for determination of personal microbial metabolite production profile for nutritional adjustment
-
10-00126
Cytotoxicity Assay for detecting Cellular Damage
-
10-00128
Functionalized Nanoparticles for Viral Clearance
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
14-00128
Blood-based tuberculosis precision medicine: transcriptomic model shortens therapy duration
-
14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
-
14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
-
14-00169
Blood-based tuberculosis precision medicine: transcriptomic model predicts treatment response
-
14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
-
15-00366
LncRNA LIPCAR predicts disease progression in heart failure and myocardial infarction patients
-
15-00411
Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
-
15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
-
15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
-
15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612 TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
-
15-00652
Biomarker Panel for Diagnosing Pulmonary Dysfunction
-
23-00046
microRNA Signature Indicates Risk for Cognitive Decline
-
32-00056
Non-invasive measurement of myocardial power
-
32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
33-00015
The Prognostic Umbilical Swab: A Rapid Molecular Risk Stratification Tool for Neonatal Sepsis and Brain Injury
-
42-00070/42-00080
Liver Function imaging of the functional hepatic reserve
-
42-00086
FAP-targeted dual imaging for guided cancer surgery
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
-
43-00034
Biomarker set for early and non-invasive diagnosis and differentiation of renal cell carcinomas
Drug Delivery
- Ref-No. Technology
-
02-00324
Innovative DOTA-Linkers for Bacterial Targeting
-
02-00351
Increased Availability and Efficacy of Aminoglycosides
-
02-00369
Biodynamers enhance drug delivery
-
02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
-
32-00091
Particle-mediated transport of dissolved active agents into hair follicles
Gastroenterology
- Ref-No. Technology
-
01-01036
Novel therapy approach for treatment of lung fibrosis
-
03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
-
11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
- 15-00436 MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
-
15-00446
Liver stem cell generation for therapeutic applications
-
15-00750
The ASGPR-CAR – a liver-specific chimeric antigen receptor
-
15-00795
Novel CARs for the Treatment of Inflammatory Bowel Disease
-
18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
42-00070/42-00080
Liver Function imaging of the functional hepatic reserve
Gene Therapy
- Ref-No. Technology
-
01-01036
Novel therapy approach for treatment of lung fibrosis
-
02-00429
WarpDemuX - Method for Demultiplexing of RNA-sequencing DATA
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
03-00553
Human TCR constructs for adoptive cell therapy of cancer
-
15-00446
Liver stem cell generation for therapeutic applications
-
15-00648
AAV Vector Variants for Ocular Gene Delivery
-
32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00101
High-level recombinant adeno-associated virus production
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00200
Gene editing of the proteinase 3 autoantigen as a novel treatment for ANCA-associated vasculitis
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
Gene Therapy Tools
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
-
02-00369
Biodynamers enhance drug delivery
-
03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
03-00453
Homology Independent Genomic Sequence Replacement
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
03-00541
Safer Sleeping Beauty transposase variants with improved integration profiles
-
03-00542
Activity-enhanced variant of hyperactive Sleeping Beauty transposase SB100X
-
15-00648
AAV Vector Variants for Ocular Gene Delivery
-
15-00728
Non-integrating alpharetrovirus-based vector particles for efficient RNA delivery and targeted gene modification
-
15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00101
High-level recombinant adeno-associated virus production
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
-
43-00004
CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient and safer CRISPR/Cas9 genome editing
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
Green Biotech
- Ref-No. Technology
-
10-00125
Consolidated Bioprocessing of Complex Carbohydrates to D-Erythro-Isocitric Acid Using a Fungus
-
10-00127
Keanumycins – Antifungal and Amoebicidal Natural Compounds for Agricultural Biocontrol
-
99-00108
Triggering of plant immunity through bacterial hydroxy fatty acid metabolites
-
99-00211
Green Rodenticide - Use of a Grayanotoxin-Based Agent for Rodent Control
Immunology/Autoimmune
- Ref-No. Technology
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
10-00128
Functionalized Nanoparticles for Viral Clearance
-
14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
-
14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
-
15-00461a
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
-
15-00461b
Novel treatment for sepsis in newborns
-
15-00538
Genetically Manipulated Cornea for Transplantation
-
15-00611
Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
-
15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
-
15-00750
The ASGPR-CAR – a liver-specific chimeric antigen receptor
-
15-00785
Novel CARs for the Treatment of Multiple Sclerosis and Alzheimer´s Disease
-
15-00795
Novel CARs for the Treatment of Inflammatory Bowel Disease
- 22-00009 Quiescent B Cells for immune suppression in gene therapy
- 22-00017 Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020 Bispecific antibodies for cell-type-specific TNF inhibition
-
23-00069
NMDAR targeted CAAR-T cell therapy
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00200
Gene editing of the proteinase 3 autoantigen as a novel treatment for ANCA-associated vasculitis
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
32-00222
Method for direct measurement of functional avidity of T cells
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
Infectious Diseases
- Ref-No. Technology
-
01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
-
02-00303
Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis
-
02-00311
Cystobactamids – novel antibacterials against gram-negative pathogens
-
02-00324
Innovative DOTA-Linkers for Bacterial Targeting
-
02-00337
Novel Labyrinthopeptins as anti-viral agents
-
02-00351
Increased Availability and Efficacy of Aminoglycosides
-
02-00354
Highly active Chlorotonil A Derivatives for the treatment of Malaria
-
02-00372
Oral Antimotilin-Based Inhibitors for Treating Helicobacter pylori Infections
-
02-00373
First-in-Class S. aureus α-Hemolysin Inhibitors for Lung and Skin Infections
-
02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
-
02-00375
CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
-
02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
-
02-00378
Best-In-Class P. aeruginosa LasB virulence factor Inhibitors
-
02-00387
Best-in-class Darobactin derivate against Gram-negative Bacteria
-
02-00396
Novel Lectin-Targeting therapeutics and diagnostics for Pseudomonas aeruginosa infections
-
02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
-
02-00402
Novel inhibitors of Cytomegalovirus
-
02-00404
Inhibitors of Energy Coupling Factor (ECF) Transporters Against Gram-Positive Pathogens
-
02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
-
02-00423
DeColi: Gut Decolonization of Multi-Resistant Escherichia coli
-
02-00432
Novel ASO-Based mRNA Silencing Technology for Phage-Host Interaction Research
-
10-00087
Jagaricin – a novel antifungal natural compound
-
10-00128
Functionalized Nanoparticles for Viral Clearance
-
14-00098
Targeting host lipid homeostasis to augment anti-mycobacterial treatment
-
14-00128
Blood-based tuberculosis precision medicine: transcriptomic model shortens therapy duration
-
14-00169
Blood-based tuberculosis precision medicine: transcriptomic model predicts treatment response
-
14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
-
15-00461b
Novel treatment for sepsis in newborns
-
18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
- 22-00020 Bispecific antibodies for cell-type-specific TNF inhibition
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00178
Broad-spectrum antiviral compounds against known and emerging viruses
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
33-00015
The Prognostic Umbilical Swab: A Rapid Molecular Risk Stratification Tool for Neonatal Sepsis and Brain Injury
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
-
44-00013
Keratinophile photosensitizers for safe and rapid treatment of onychomycosis
Medical Devices
- Ref-No. Technology
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
15-00433
Bioartificial vascular grafts based on a highly compacted acellular fibrin matrix
-
15-00490
Irradiation device and method for optical cochlear implants and laser surgery sytems
-
15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
-
15-00577
Effective prevention of biofilm-associated infections on dental implants
-
15-00617
Spider silk/fibrin implant for the regeneration of injured spinal cord
-
21-00019
Microelectrode array with combined optical stimulation
-
21-00032
“Multiplextrode” – a completely novel electrode for analogue multiplexing
-
32-00030
Method and arrangement for identification and correction of optical aberrations
-
32-00056
Non-invasive measurement of myocardial power
- 32-00058 Blood transfusion safety system Cairos
-
32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
32-00108
Fiber Membrane Oxygenator with Minimized Priming Volume
-
42-00036
Novel gas flow system for high throughput determination of oxygen dissociation curves (ODC)
-
99-00153
Ultra-thin imaging fiber endoscope using a diffuser as encoder and a deep neural network as decoder
Metabolic Diseases
- Ref-No. Technology
-
01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
-
03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
-
11-00062
UV-Fit – increasing metabolic fitness and reducing body weight without fasting
-
11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
-
11-00068
Dream Complex Inhibitors for Treating Medical Conditions Induced by Circadian Rhythm Disruption
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
32-00071
A scalable and highly sensitive assay for measuring extracellular NAD+ level in human body fluids
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
Oncology
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
01-01080
Drug combinations to overcome therapy resistance in cancer
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
-
03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
-
14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
-
14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
-
15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
-
15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
-
15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612 TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
-
15-00751
Prediction of L-Asparaginase resistance in tumor therapy
- 22-00017 Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
-
32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
-
32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
-
32-00099
A novel immuno-oncology approach for induction and massive amplification of antigen-specific cytotoxic CD8+ T-cells
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
42-00076
NICHE-CAR-T: NR2F6 Immune Checkpoint Harnessing to Enhance CAR-T efficacy
-
42-00086
FAP-targeted dual imaging for guided cancer surgery
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
-
43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
-
43-00034
Biomarker set for early and non-invasive diagnosis and differentiation of renal cell carcinomas
Other Indications
- Ref-No. Technology
-
02-00425
Efficient Generation of Murine Brain Organoids from Adult Neural Stem Cells
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00493
Self-Organizing Human 2D Neuromuscular Junction Model and 3D Neuromuscular Organoids
-
11-00062
UV-Fit – increasing metabolic fitness and reducing body weight without fasting
-
11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
-
11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
-
11-00068
Dream Complex Inhibitors for Treating Medical Conditions Induced by Circadian Rhythm Disruption
-
15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
-
15-00555
Method for high-yield production of megakaryocytes
-
15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
-
32-00030
Method and arrangement for identification and correction of optical aberrations
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
42-00047
Tyrolian algae extract with anti-inflammatory potential
Research Tools
- Ref-No. Technology
- 01-00366 Human Voxel Models
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
-
01-01070
AI-based Method and Tool (DeepNeo) for Intravascular Optical Coherence Tomography Image Analysis of Coronary Artery Neointimal Tissue
-
02-00369
Biodynamers enhance drug delivery
-
02-00380
Prediction for targeting efficiency of guide RNA for a gene of interest in bacteria
-
02-99999
Metax: Cross-Domain Metagenomic Profiling Technology
-
03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
-
03-00384
Short Term Isotope Pulse Labeling Method for Analyzing Metabolic States and Drug Targets in Biological Samples
-
03-00390
Genome Architecture Mapping (GAM)
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
03-00453
Homology Independent Genomic Sequence Replacement
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
03-00461
Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
-
03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
-
03-00470
FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
-
03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
-
03-00493
Self-Organizing Human 2D Neuromuscular Junction Model and 3D Neuromuscular Organoids
-
03-00515
Advancing Bioproduction: HDLBP overexpression enhances protein production and secretion
-
03-00539
Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 07-00080 Innovative plasmids and cells for SARS-CoV-2-specific research
- 11-00035 Cell wall-less bacteria (L-forms) for high yield heterologous protein expression
-
11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
-
11-00066
ProteasomeID - Quantitative mapping of proteasome interactomes and substrates in vitro and in vivo
- 14-00013 MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022 Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
-
14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
-
15-00733
Automated production of cardiac organoids
-
21-00031
Wireless Miniature Microscope For Near-Field Image-Capturing
-
32-00030
Method and arrangement for identification and correction of optical aberrations
-
32-00071
A scalable and highly sensitive assay for measuring extracellular NAD+ level in human body fluids
-
32-00101
High-level recombinant adeno-associated virus production
-
32-00123
Method for tuning brain network models for the implementation of brain digital twins
-
32-00124
CD3-CAR NK-92 cell-mediated TCR+ depletion
-
32-00128
Method for Assessing Out-of-Specification (OOS) CAR T-Cell Products and Predicting Patient Response
-
32-00181
Advanced tracer compounds for enhanced detection of cellular structures
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00202
An engineered serine integrase for targeted gene transfer in human cells
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
-
40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
-
43-00004
CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient and safer CRISPR/Cas9 genome editing
-
43-00013
CRISPR StAR: facilitating high resolution genetic screening in complex in vivo models
-
43-00016
Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis
-
43-00017
SCON – Artificial intron devoid of hypomorphic target gene effects for one-step generation of conditional animal models
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
Software
- Ref-No. Technology
- 01-00366 Human Voxel Models
-
01-01070
AI-based Method and Tool (DeepNeo) for Intravascular Optical Coherence Tomography Image Analysis of Coronary Artery Neointimal Tissue
-
02-00380
Prediction for targeting efficiency of guide RNA for a gene of interest in bacteria
-
02-00429
WarpDemuX - Method for Demultiplexing of RNA-sequencing DATA
-
02-00430
Drug Dosage Optimization Based on Machine Learning and Mechanistic Modeling
-
03-00431
CrispRGold - Design of efficient CrispR/Cas sgRNA sequences and off-target prediction
-
11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
-
15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
-
32-00056
Non-invasive measurement of myocardial power
- 32-00058 Blood transfusion safety system Cairos
-
32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
-
32-00123
Method for tuning brain network models for the implementation of brain digital twins
Technical Equipment
- Ref-No. Technology
-
03-00384
Short Term Isotope Pulse Labeling Method for Analyzing Metabolic States and Drug Targets in Biological Samples
-
03-00459
Autofocus-control of a microscope including an electrically tunable lens
-
15-00490
Irradiation device and method for optical cochlear implants and laser surgery sytems
-
21-00019
Microelectrode array with combined optical stimulation
-
21-00031
Wireless Miniature Microscope For Near-Field Image-Capturing
-
21-00032
“Multiplextrode” – a completely novel electrode for analogue multiplexing
-
32-00030
Method and arrangement for identification and correction of optical aberrations
- 32-00058 Blood transfusion safety system Cairos
-
32-00108
Fiber Membrane Oxygenator with Minimized Priming Volume
-
32-00174
Injection tunnel for stress-reduced handling of laboratory mice
-
43-00026
Efficient multiplex cryo-embedding method for cost-efficient, high-throughput tissue analysis
Therapeutics
- Ref-No. Technology
-
01-01036
Novel therapy approach for treatment of lung fibrosis
-
01-01080
Drug combinations to overcome therapy resistance in cancer
-
01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
-
02-00311
Cystobactamids – novel antibacterials against gram-negative pathogens
-
02-00337
Novel Labyrinthopeptins as anti-viral agents
-
02-00351
Increased Availability and Efficacy of Aminoglycosides
-
02-00354
Highly active Chlorotonil A Derivatives for the treatment of Malaria
-
02-00369
Biodynamers enhance drug delivery
-
02-00372
Oral Antimotilin-Based Inhibitors for Treating Helicobacter pylori Infections
-
02-00373
First-in-Class S. aureus α-Hemolysin Inhibitors for Lung and Skin Infections
-
02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
-
02-00378
Best-In-Class P. aeruginosa LasB virulence factor Inhibitors
-
02-00385
Next-Generation Probiotics
-
02-00387
Best-in-class Darobactin derivate against Gram-negative Bacteria
-
02-00396
Novel Lectin-Targeting therapeutics and diagnostics for Pseudomonas aeruginosa infections
-
02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
-
02-00402
Novel inhibitors of Cytomegalovirus
-
02-00404
Inhibitors of Energy Coupling Factor (ECF) Transporters Against Gram-Positive Pathogens
-
02-00415
Thiourea-Based Antibiotics against Acinetobacter baumannii
-
02-00423
DeColi: Gut Decolonization of Multi-Resistant Escherichia coli
-
02-00432
Novel ASO-Based mRNA Silencing Technology for Phage-Host Interaction Research
-
03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00367 Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
-
03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
-
03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
-
03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
-
03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
-
03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
-
03-00553
Human TCR constructs for adoptive cell therapy of cancer
-
10-00087
Jagaricin – a novel antifungal natural compound
-
10-00128
Functionalized Nanoparticles for Viral Clearance
-
11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
-
11-00068
Dream Complex Inhibitors for Treating Medical Conditions Induced by Circadian Rhythm Disruption
- 15-00436 MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
-
15-00446
Liver stem cell generation for therapeutic applications
-
15-00461a
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
-
15-00461b
Novel treatment for sepsis in newborns
-
15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
-
15-00611
Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
- 15-00612 TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
-
15-00648
AAV Vector Variants for Ocular Gene Delivery
-
15-00651
Novel Treatment of Pulmonary Arterial Hypertension (PAH)
-
15-00694
HLA-DR-specific γδ T-cell receptor to treat proliferative disorders of HLA-DR+ cells
-
21-00019
Microelectrode array with combined optical stimulation
-
21-00027
Ferulic acid derivatives as efficient neuroprotective agent and memory enhancer
-
21-00035
Novel Therapy for Treatment of Alzheimer´s Disease
- 22-00009 Quiescent B Cells for immune suppression in gene therapy
- 22-00017 Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020 Bispecific antibodies for cell-type-specific TNF inhibition
-
23-00046
microRNA Signature Indicates Risk for Cognitive Decline
-
23-00064
Treating dementia and other brain disorders with natural glycans
- 23-00065 Novel treatment of dementia-associated tauopathies
-
23-00069
NMDAR targeted CAAR-T cell therapy
-
23-00075
HERV inhibitors for use in tauopathies
-
32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
-
32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
-
32-00082
Reprogramming immune cells for CAR cell-based therapies
-
32-00083
Immunosuppressant resistance in anti-viral T cell products
-
32-00099
A novel immuno-oncology approach for induction and massive amplification of antigen-specific cytotoxic CD8+ T-cells
-
32-00101
High-level recombinant adeno-associated virus production
-
32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
-
32-00192
Base editing enzymes for multiplex editing with simultaneous gene knock-in and knock-out
-
32-00222
Method for direct measurement of functional avidity of T cells
-
42-00047
Tyrolian algae extract with anti-inflammatory potential
-
42-00076
NICHE-CAR-T: NR2F6 Immune Checkpoint Harnessing to Enhance CAR-T efficacy
-
44-00013
Keratinophile photosensitizers for safe and rapid treatment of onychomycosis
Vaccines
- Ref-No. Technology
-
02-00158
Cyclic di-Nucleotides as adjuvants
-
02-00361
Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
-
02-00369
Biodynamers enhance drug delivery
-
02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
-
02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
-
14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
-
15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00527 New Class of Bacterial Capsule Polymerases for Cost-Effective Synthesis of Glycoconjugate Vaccines
-
18-00054
VSV-encoded HCV vaccines that induce broadly neutralising antibodies against Hepatitis C
- 23-00074 Treating C9orf72 ALS/FTD with active vaccination
-
32-00099
A novel immuno-oncology approach for induction and massive amplification of antigen-specific cytotoxic CD8+ T-cells
